A BREAST cancer drug which reportedly prolongs the lives of women in advanced stages of the condition is to be produced in Cork after pharmaceutical company GlaxoSmithKline received an EU licence for the treatment.

A new breast cancer drug has been shown to slow down the progression of advanced cases of the disease by more than 50%, drug company GlaxoSmithKline said today.